Stock Research: Maravai LifeSciences Holdings

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Maravai LifeSciences Holdings

NSQ:MRVI US56600D1072
94
  • Value
    79
  • Growth
    63
  • Safety
    Safety
    72
  • Combined
    92
  • Sentiment
    61
  • 360° View
    360° View
    94
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

ANALYSIS: With an Obermatt 360° View of 94 (better than 94% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Maravai LifeSciences Holdings are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Maravai LifeSciences Holdings. The consolidated Value Rank has an attractive rank of 79, which means that the share price of Maravai LifeSciences Holdings is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 79% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 63, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 72. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 61. ...read more

more
Index
NASDAQ
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
79 n/a n/a n/a
Growth
63 n/a n/a n/a
Safety
Safety
72 n/a n/a n/a
Sentiment
61 n/a n/a n/a
360° View
360° View
94 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
21 n/a n/a n/a
Opinions Change
50 n/a n/a n/a
Pro Holdings
n/a n/a n/a n/a
Market Pulse
86 n/a n/a n/a
Sentiment
61 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
79 n/a n/a n/a
Growth
63 n/a n/a n/a
Safety Safety
72 n/a n/a n/a
Combined
92 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
69 n/a n/a n/a
Price vs. Earnings (P/E)
76 n/a n/a n/a
Price vs. Book (P/B)
52 n/a n/a n/a
Dividend Yield
1 n/a n/a n/a
Value
79 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
51 n/a n/a n/a
Profit Growth
34 n/a n/a n/a
Capital Growth
86 n/a n/a n/a
Stock Returns
59 n/a n/a n/a
Growth
63 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
41 n/a n/a n/a
Refinancing
87 n/a n/a n/a
Liquidity
42 n/a n/a n/a
Safety Safety
72 n/a n/a n/a

Similar Stocks

Discover high‑ranked alternatives to Maravai LifeSciences Holdings and broaden your portfolio horizons.

Zimmer

NYQ:ZBH
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Revvity

NYQ:RVTY
Country: USA
Industry: Life Sciences Tools & Services
Size: Large
Full Stock Analysis

Stewart Information

NYQ:STC
Country: USA
Industry: Property & Casualty Insurance
Size: Medium
Full Stock Analysis

FedEx

NYQ:FDX
Country: USA
Industry: Air Freight & Logistics
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

This is an all-around strong stock. It shows good value, high growth, safe financing, and positive professional sentiment. It is ideal for most buy-and-hold investors who value a good all-around stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: